Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin

Chen X, Soma LA, Fromm JR

OncoTargets and Therapy 2014, 7:45-56

Published Date: 19 December 2013